within Pharmacolibrary.Drugs.C_CardiovascularSystem.C10A_LipidModifyingAgentsPlain.C10AB05_Fenofibrate;

model Fenofibrate
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.6,
    Cl = 4.444444444444445e-07,
    adminDuration = 600,
    adminMass = 200 / 1000000,
    adminCount = 1,
    Vd = 0.035,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0045000000000000005,
    Tlag = 60.0);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Fenofibrate</td></tr><tr><td>ATC code:</td><td>C10AB05</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>200</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>35</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.6</td><td>L/hr</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Fenofibrate is a lipid-lowering agent that belongs to the class of fibric acid derivatives. It is used primarily to reduce cholesterol and triglycerides (types of fat) in the blood. It is approved for the treatment of hypercholesterolemia and mixed dyslipidemia, often as an adjunct to diet. Fenofibrate is currently approved and widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers after single-dose oral administration of micronized fenofibrate.</p><h4>References</h4><ol><li><p>Godfrey, AR, et al., &amp; Davis, MW (2011). Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials. <i>Clinical therapeutics</i> 33(6) 766–775. DOI:<a href=\"https://doi.org/10.1016/j.clinthera.2011.05.047\">10.1016/j.clinthera.2011.05.047</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21704241/\">https://pubmed.ncbi.nlm.nih.gov/21704241</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.C.C10AB05 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Fenofibrate;
